Exploring the molecular aspects associated with testicular germ cell tumors: a review

Gaetano Facchini; Sabrina Rossetti; Carla Cavaliere; Carmine D’Aniello; Rossella Di Franco; Gelsomina Iovane; Giovanni Grimaldi; Raffaele Piscitelli; Paolo Muto; Gerardo Botti; Sisto Perdonà; Bianca Maria Veneziani; Massimiliano Berretta; Micaela Montanari

doi:10.18632/oncotarget.22373

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Exploring the molecular aspects associated with testicular germ cell tumors: a review

Gaetano Facchini, Sabrina Rossetti, Carla Cavaliere, Carmine D’Aniello, Rossella Di Franco, Gelsomina Iovane, Giovanni Grimaldi, Raffaele Piscitelli, Paolo Muto, Gerardo Botti, Sisto Perdonà, Bianca Maria Veneziani, Massimiliano Berretta and Micaela Montanari _

PDF | HTML | How to cite

Oncotarget. 2018; 9:1365-1379. https://doi.org/10.18632/oncotarget.22373

Metrics: PDF 1520 views | HTML 3707 views | ?

Abstract

Gaetano Facchini1,2, Sabrina Rossetti1,2, Carla Cavaliere3, Carmine D’Aniello4, Rossella Di Franco1,5, Gelsomina Iovane1,2, Giovanni Grimaldi6, Raffaele Piscitelli1, Paolo Muto5, Gerardo Botti7,8, Sisto Perdonà6, Bianca Maria Veneziani9, Massimiliano Berretta10 and Micaela Montanari1,9,11

1Progetto ONCONET2.0, Linea Progettuale 14 per l’Implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy

2S.S.D Oncologia Clinica Sperimentale Uro-Andrologica, Dipartimento Corp-S Assistenziale dei Percorsi Oncologici Uro-Genitale, Istituto Nazionale Tumori “Fondazione G. Pascale”, IRCCS, Naples, Italy

3Medical Oncology Unit, ASL NA 3 SUD, Ospedali Riuniti Area Nolana, Nola, Italy

4Division of Medical Oncology, A.O.R.N. dei COLLI "Ospedali Monaldi-Cotugno-CTO", Naples, Italy

5Radiation Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione Giovanni Pascale”, IRCCS, Naples, Italy

6Division of Urology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori “Fondazione G. Pascale”, IRCCS, Naples, Italy

7Pathology Unit, Istituto Nazionale Tumori “Fondazione G. Pascale”, IRCCS, Naples, Italy

8Scientific Management, Istituto Nazionale Tumori “Fondazione G. Pascale”, IRCCS, Naples, Italy

9Department of Molecular Medicine and Medical Biotechnologies, University of Naples “Federico II”, Naples, Italy

10Department of Medical Oncology, CRO Aviano, National Cancer Institute, Aviano, Italy

11Department of Biology, College of Science and Technology, Temple University, Philadelphia, USA

Correspondence to:

Micaela Montanari, email: [email protected]

Keywords: TGCTs, epigenetics, chemosensitivity, cisplatin-associated resistance

Received: September 30, 2017 Accepted: October 05, 2017 Published: November 03, 2017

ABSTRACT

Testicular germ cell tumors (TGCTs) represent the most common solid tumors affecting young men. They constitute a distinct entity because of their embryonic origin and their unique biological behavior. Recent preclinical data regarding biological signaling machinery as well as genetic and epigenetic mechanisms associated with molecular patterns of tumors have contribute to explain the pathogenesis and the differentiation of TGCTs and to understand the mechanisms responsible for the development of resistance to treatment. In this review, we discuss the main genetic and epigenetic events associated with TGCTs development in order to better define their role in the pathogenesis of these tumors and in cisplatin-acquired resistance.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22373

Publication Alerts

Reviews:

Exploring the molecular aspects associated with testicular germ cell tumors: a review

Abstract